These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 2570613)

  • 1. [Why is it sometimes necessary to include a large number of patients in clinical trials?].
    Hill C
    Bull Cancer; 1989; 76(6):569-71. PubMed ID: 2570613
    [No Abstract]   [Full Text] [Related]  

  • 2. Letter to the Editor re Yu and Holmgren. Traditional endpoint of progression-free survival (PFS) may not be appropriate for evaluating cytostatic agents combined with chemotherapy in cancer clinical trials.
    Mietlowski W; Wang J
    Contemp Clin Trials; 2007 Sep; 28(5):674. PubMed ID: 17449334
    [No Abstract]   [Full Text] [Related]  

  • 3. Modern drug treatment--No. 8. Drugs and the prevention of death from myocardial infarction.
    Graham IM
    Ir Med J; 1982 Aug; 75(8):291-6. PubMed ID: 6127329
    [No Abstract]   [Full Text] [Related]  

  • 4. Future possibilities for conducting clinical trials to test the efficacy of beta-blocker medications.
    Naughton J
    Circulation; 1983 Jun; 67(6 Pt 2):I106-9. PubMed ID: 6133639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical trials and ischaemic heart disease: can drugs reduce coronary mortality?
    Silke B; Nelson GI; Taylor SH
    Ir Med J; 1982 Aug; 75(8):297-303. PubMed ID: 6127330
    [No Abstract]   [Full Text] [Related]  

  • 6. Breast tumours: a review of adjuvant chemotherapy trials.
    Plagne R
    Drugs Exp Clin Res; 1986; 12(1-3):135-42. PubMed ID: 3525067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta-adrenergic blockade after myocardial infarction: clinical and public health implications of the reported beta-blocker clinical trials.
    Friedewald WT
    Circulation; 1983 Jun; 67(6 Pt 2):I110-1. PubMed ID: 6133641
    [No Abstract]   [Full Text] [Related]  

  • 8. Response surface methodology and the design of clinical trials for the evaluation of cancer chemotherapy.
    Carter WH
    Cancer Treat Rep; 1985 Oct; 69(10):1049-53. PubMed ID: 4042084
    [No Abstract]   [Full Text] [Related]  

  • 9. A review of acute-phase beta-blocker trials in patients with myocardial infarction.
    May GS
    Circulation; 1983 Jun; 67(6 Pt 2):I21-5. PubMed ID: 6133643
    [No Abstract]   [Full Text] [Related]  

  • 10. beta Blockade after myocardial infarction. Absence of evidence is failure of research policy.
    Lipman T
    BMJ; 2000 Feb; 320(7234):581. PubMed ID: 10744406
    [No Abstract]   [Full Text] [Related]  

  • 11. Beta blocking agents in post myocardial infarction patients.
    Campbell RW; Bourke J
    Eur Heart J; 1986 May; 7 Suppl A():119-21. PubMed ID: 2873038
    [No Abstract]   [Full Text] [Related]  

  • 12. A review of long-term beta-blocker trials in survivors of myocardial infarction.
    May GS
    Circulation; 1983 Jun; 67(6 Pt 2):I46-9. PubMed ID: 6133644
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical trial design in metastatic breast cancer: a commentary.
    Levine M
    Can J Oncol; 1995 Dec; 5 Suppl 1():40-2. PubMed ID: 8853523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical trials referral resource. Clinical trials in elderly patients.
    Cheson BD; Nelson A
    Oncology (Williston Park); 1997 Jun; 11(6):838, 844. PubMed ID: 9189940
    [No Abstract]   [Full Text] [Related]  

  • 15. The role of beta-blockers in the treatment of patients after infarction.
    Pratt CM; Young JB; Roberts R
    Cardiol Clin; 1984 Feb; 2(1):13-20. PubMed ID: 6152718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prophylactic use of beta-adrenergic blockade in survivors of myocardial infarction.
    Rotmensch HH; Vlasses PH; Ferguson RK
    Heart Lung; 1984 Jul; 13(4):366-71. PubMed ID: 6145686
    [No Abstract]   [Full Text] [Related]  

  • 17. Factorial designs for randomized clinical trials.
    Byar DP; Piantadosi S
    Cancer Treat Rep; 1985 Oct; 69(10):1055-63. PubMed ID: 4042085
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical trial designs based on sequential conditional probability ratio tests and reverse stochastic curtailing.
    Tan M; Xiong X; Kutner MH
    Biometrics; 1998 Jun; 54(2):682-95. PubMed ID: 9629648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of beta-adrenergic blocking agents after myocardial infarction.
    Talbert RL
    Clin Pharm; 1983; 2(1):68-74. PubMed ID: 6136362
    [No Abstract]   [Full Text] [Related]  

  • 20. Beta blockers and calcium channel blocking agents in acute myocardial infarction.
    Pearle DL; Rackley CE
    Cardiovasc Clin; 1986; 16(3):29-38. PubMed ID: 2875793
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.